.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AE03_Argatroban.Argatroban .Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AE03_Argatroban.Argatroban| name: | Argatroban | |
| ATC code: | B01AE03 | route: | intravenous |
| compartments: | 2 | |
| dosage: | 2 | mg |
| volume of distribution: | 174 | L |
| clearance: | 5.1 | ml/kg/min |
| other parameters in model implementation | ||
Argatroban is a synthetic direct thrombin inhibitor used primarily as an anticoagulant in the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT). It is approved for clinical use and is administered intravenously, especially in situations where heparin is contraindicated.
Pharmacokinetic parameters in healthy adult subjects following intravenous infusion.